ALLIANCEBERNSTEIN L.P. - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 65 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 9.29 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2014$1,000590.0%0.00%
Q4 2013$0
-100.0%
59
-98.4%
0.00%
Q3 2013$35,000
-14.6%
3,759
-11.0%
0.00%
Q2 2013$41,0004,2230.00%
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q2 2013
NameSharesValueWeighting ↓
Abingworth LLP 396,104$400,0000.42%
Ancora Advisors LLC 50,865$51,0000.01%
Acrospire Investment Management LLC 5,200$5,0000.00%
EAGLE GLOBAL ADVISORS LLC 145,710$146,0000.00%
A.R.T. Advisors, LLC 57,954$57,0000.00%
Renaissance Technologies 876,100$876,0000.00%
PANAGORA ASSET MANAGEMENT INC 133,846$134,0000.00%
Cutler Group LLC / CA 11,048$11,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 4,600$5,0000.00%
Timber Hill LLC 10,663$11,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders